{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:17:28Z","timestamp":1795209448283,"version":"4.10.3"},"reference-count":87,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00238039"],"award-info":[{"award-number":["RS-2023-00238039"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Soonchunhyang University Research Fund"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Alcohol-associated liver disease (ALD) includes a spectrum from steatosis and steatohepatitis to cirrhosis and hepatocellular carcinoma driven by oxidative stress, immune activation, and systemic inflammation. Ethanol metabolism through alcohol dehydrogenase, aldehyde dehydrogenase, and cytochrome P450 2E1 generates reactive oxygen and nitrogen species, leading to mitochondrial dysfunction, hepatocellular injury, and activation of inflammatory and fibrogenic pathways. Beyond hepatic effects, ALD engages the gut\u2013liver\u2013brain axis, where microbial dysbiosis, blood\u2013brain barrier disruption, and neuroinflammation contribute to cognitive impairment and cerebrovascular risk. The emerging concept, metabolic dysfunction-associated steatotic liver disease and increased alcohol intake (MetALD), presents the synergistic impact of alcohol and metabolic comorbidities, enhancing oxidative injury and fibrosis. This review summarizes key mechanisms connecting oxidative stress to multisystem pathology and highlights the need for precision therapies targeting redox imbalance, immune dysregulation, and gut\u2013brain\u2013liver interactions to improve outcomes in ALD and MetALD.<\/jats:p>","DOI":"10.3390\/antiox14101196","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:37:21Z","timestamp":1759311441000},"page":"1196","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Alcohol-Induced Oxidative Stress and Gut\u2013Liver\u2013Brain Crosstalk: Expanding the Paradigm from ALD to MetALD"],"prefix":"10.3390","volume":"14","author":[{"given":"Jeong-Yoon","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Neurology, Soonchunhyang University College of Medicine, Seoul 04401, Republic of Korea"},{"name":"Department of Translational Medicine, Graduate School of Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0778-2274","authenticated-orcid":false,"given":"Young-Min","family":"Jee","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Soonchunhyang University College of Medicine, Seoul 04401, Republic of Korea"},{"name":"Department of Family Medicine, Graduate School of Medicine, Seoul National University College of Medicine, Seoul 08826, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keungmo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul 04401, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mackowiak, B., Fu, Y., Maccioni, L., and Gao, B. (2024). Alcohol-associated liver disease. J. Clin. Investig., 134.","DOI":"10.1172\/JCI176345"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.3350\/cmh.2022.0393","article-title":"The effects of moderate alcohol consumption on non-alcoholic fatty liver disease","volume":"29","author":"Oh","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4254\/wjh.v12.i7.332","article-title":"Oxidative stress in alcohol-related liver disease","volume":"12","author":"Tan","year":"2020","journal-title":"World J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Radosavljevic, T., Brankovic, M., Djuretic, J., Grujic-Milanovic, J., Kovacic, M., Jevtic, J., Stankovic, S., Samardzic, J., Vucevic, D., and Jakovljevic, V. (2024). Alpinetin Exhibits Antioxidant and Anti-Inflammatory Effects in C57BL\/6 Mice with Alcoholic Liver Disease Induced by the Lieber-DeCarli Ethanol Liquid Diet. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010086"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cmet.2019.08.001","article-title":"Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis","volume":"30","author":"Choi","year":"2019","journal-title":"Cell Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/hep.31875","article-title":"Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells","volume":"74","author":"Choi","year":"2021","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gupta, H., Suk, K.T., and Kim, D.J. (2021). Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030541"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e70017","DOI":"10.1111\/liv.70017","article-title":"MetALD: New Perspectives on an Old Overlooked Disease","volume":"45","author":"Ayares","year":"2025","journal-title":"Liver Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3350\/cmh.2024.0315","article-title":"Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives","volume":"30","author":"Yan","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Zhang, T., Kusumanchi, P., Han, S., Yang, Z., and Liangpunsakul, S. (2020). Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease. Biomedicines, 8.","DOI":"10.3390\/biomedicines8030050"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7150\/ijbs.42300","article-title":"Aldehyde Dehydrogenase, Liver Disease and Cancer","volume":"16","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_15","first-page":"5","article-title":"The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde dehydrogenase variants","volume":"30","author":"Edenberg","year":"2007","journal-title":"Alcohol Res. Health"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shi, Y., Liu, Y., Wang, S., Huang, J., Luo, Z., Jiang, M., Lu, Y., Lin, Q., Liu, H., and Cheng, N. (2022). Endoplasmic reticulum-targeted inhibition of CYP2E1 with vitamin E nanoemulsions alleviates hepatocyte oxidative stress and reverses alcoholic liver disease. Biomaterials, 288.","DOI":"10.1016\/j.biomaterials.2022.121720"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Shiba, S., Nakamoto, N., Chu, P.S., Ojiro, K., Taniki, N., Yamaguchi, A., Morikawa, R., Katayama, T., Yoshida, A., and Aoki, R. (2021). Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-93086-y"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molmed.2017.12.003","article-title":"Aldehyde-Induced DNA and Protein Adducts as Biomarker Tools for Alcohol Use Disorder","volume":"24","author":"Heymann","year":"2018","journal-title":"Trends Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.redox.2014.09.005","article-title":"Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress","volume":"3","author":"Mari","year":"2014","journal-title":"Redox Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Song, H., Lee, J., Lee, Y., Kim, S., and Kang, S. (2025). Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer\u2019s Disease with Therapeutic Implications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073272"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Afzal, S., Abdul Manap, A.S., Attiq, A., Albokhadaim, I., Kandeel, M., and Alhojaily, S.M. (2023). From imbalance to impairment: The central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1269581"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Juan, C.A., Perez de la Lastra, J.M., Plou, F.J., and Perez-Lebena, E. (2021). The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094642"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Song, J., Xiao, L., Zhang, Z., Wang, Y., Kouis, P., Rasmussen, L.J., and Dai, F. (2024). Effects of reactive oxygen species and mitochondrial dysfunction on reproductive aging. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1347286"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","article-title":"Effect of ethanol on lipid metabolism","volume":"70","author":"You","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101195","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD(+) in regulating cellular and metabolic signaling pathways","volume":"49","author":"Amjad","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41423-025-01291-w","article-title":"Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease","volume":"22","author":"Shen","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2020.04.033","article-title":"Danger signals in liver injury and restoration of homeostasis","volume":"73","author":"Han","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2023.05.017","article-title":"The role of neutrophils in alcohol-related hepatitis","volume":"79","author":"Khan","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.12998\/wjcc.v10.i12.3662","article-title":"Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis","volume":"10","author":"Garbuzenko","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.livres.2024.06.002","article-title":"Role of immune cell interactions in alcohol-associated liver diseases","volume":"8","author":"Wang","year":"2024","journal-title":"Liver Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.31041","article-title":"Mitochondrial Double-Stranded RNA in Exosome Promotes Interleukin-17 Production Through Toll-Like Receptor 3 in Alcohol-associated Liver Injury","volume":"72","author":"Lee","year":"2020","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101414","DOI":"10.1016\/j.jhepr.2025.101414","article-title":"Inflammation in MASLD progression and cancer","volume":"7","author":"Kim","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: Mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41419-022-05444-x","article-title":"Endoplasmic reticulum stress-mediated cell death in liver injury","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41418-023-01118-z","article-title":"The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cells","volume":"30","author":"Sun","year":"2023","journal-title":"Cell Death Differ."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Saha, B., Pallatt, S., Banerjee, A., Banerjee, A.G., Pathak, R., and Pathak, S. (2024). Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage. Cells, 13.","DOI":"10.3390\/cells13181560"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.gendis.2021.12.006","article-title":"Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis","volume":"10","author":"Charan","year":"2023","journal-title":"Genes Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Yang, Y.M., Cho, Y.E., and Hwang, S. (2022). Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020774"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kamal, H., Tan, G.C., Ibrahim, S.F., Shaikh, M.F., Mohamed, I.N., Mohamed, R.M.P., Hamid, A.A., Ugusman, A., and Kumar, J. (2020). Alcohol Use Disorder, Neurodegeneration, Alzheimer\u2019s and Parkinson\u2019s Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.00282"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Han, J., Lee, C., Hur, J., and Jung, Y. (2022). Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease. Cells, 12.","DOI":"10.3390\/cells12010022"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/j.1530-0277.2011.01547.x","article-title":"S-adenosyl-L-methionine treatment for alcoholic liver disease: A double-blinded, randomized, placebo-controlled trial","volume":"35","author":"Medici","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jgh.16199","article-title":"Alcohol, the gut microbiome, and liver disease","volume":"38","author":"Jew","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2393272","DOI":"10.1080\/19490976.2024.2393272","article-title":"Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: A review","volume":"16","author":"Sosnowski","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chen, G., Shi, F., Yin, W., Guo, Y., Liu, A., Shuai, J., and Sun, J. (2022). Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.916765"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The role of the gut microbiome in chronic liver disease: The clinical evidence revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Visekruna, A., and Luu, M. (2021). The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.703218"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Harberts, A., and Schnabl, B. (2025). Microbiota in Alcohol-Associated Organ Damage. Am. J. Pathol., in press.","DOI":"10.1016\/j.ajpath.2025.05.012"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6733477","DOI":"10.1155\/mi\/6733477","article-title":"Unraveling the Gut-Liver-Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches","volume":"2025","author":"Aghara","year":"2025","journal-title":"Mediat. Inflamm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2018.12.007","article-title":"Neuroimmune signaling in alcohol use disorder","volume":"177","author":"Erickson","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pmbts.2015.10.018","article-title":"Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings","volume":"137","author":"Bell","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_54","first-page":"209","article-title":"Alcohol, inflammation, and blood-brain barrier function in health and disease across development","volume":"161","author":"Vore","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroscience.2025.06.037","article-title":"Role of Blood-Brain barrier in bacterial translocation","volume":"580","author":"Aborode","year":"2025","journal-title":"Neuroscience"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"213286","DOI":"10.1155\/2011\/213286","article-title":"Acetaldehyde-mediated neurotoxicity: Relevance to fetal alcohol spectrum disorders","volume":"2011","author":"Tong","year":"2011","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"101740","DOI":"10.1016\/j.aohep.2024.101740","article-title":"Brain reserve in hepatic encephalopathy: Pathways of damage and preventive strategies through lifestyle and therapeutic interventions","volume":"30","author":"Ampuero","year":"2025","journal-title":"Ann. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Simpson, D.S.A., and Oliver, P.L. (2020). ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease. Antioxidants, 9.","DOI":"10.3390\/antiox9080743"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.35946\/arcr.v38.2.06","article-title":"Alcohol\u2019s Effects on the Cardiovascular System","volume":"38","author":"Piano","year":"2017","journal-title":"Alcohol. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-023-01590-1","article-title":"Chronic cerebral hypoperfusion: A critical feature in unravelling the etiology of vascular cognitive impairment","volume":"11","author":"Rajeev","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-025-00849-6","article-title":"Bridging systemic metabolic dysfunction and Alzheimer\u2019s disease: The liver interface","volume":"20","author":"Song","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cld.2013.09.006","article-title":"The impact of obesity and metabolic syndrome on alcoholic liver disease","volume":"18","author":"Chiang","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3350\/cmh.2023.0277","article-title":"Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44355-024-00014-8","article-title":"Metabolic and alcohol-associated liver disease (MetALD): A representation of duality","volume":"2","author":"Cubero","year":"2025","journal-title":"npj Gut Liver"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Hong, X., Huang, S., Jiang, H., Ma, Q., Qiu, J., Luo, Q., Cao, C., Xu, Y., Chen, F., and Chen, Y. (2024). Alcohol-related liver disease (ALD): Current perspectives on pathogenesis, therapeutic strategies, and animal models. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1432480"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/apt.18286","article-title":"Metabolic dysfunction-associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study","volume":"60","author":"Park","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: A nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00213-013-3226-2","article-title":"Glutamatergic targets for new alcohol medications","volume":"229","author":"Holmes","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12974-020-01972-5","article-title":"Chronic alcohol-induced neuroinflammation involves CCR2\/5-dependent peripheral macrophage infiltration and microglia alterations","volume":"17","author":"Lowe","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Acierno, C., Barletta, F., Caturano, A., Nevola, R., Sasso, F.C., Adinolfi, L.E., and Rinaldi, L. (2025). Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights. Nutrients, 17.","DOI":"10.3390\/nu17132229"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/ITT.S499605","article-title":"Interplay Between Insulin Resistance and Immune Dysregulation in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions","volume":"14","author":"Berbudi","year":"2025","journal-title":"Immunotargets Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1007\/s10620-020-06142-4","article-title":"A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis","volume":"65","author":"Amjad","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: A review","volume":"23","author":"Singh","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/liv.15701","article-title":"Management of alcoholic hepatitis: A clinical perspective","volume":"43","author":"Kasper","year":"2023","journal-title":"Liver Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Rady, E.D., Anouti, A., Mitchell, M.C., and Cotter, T.G. (2025). Current Clinical Trials for Alcohol-Associated Hepatitis. Am. J. Pathol., in press.","DOI":"10.1016\/j.ajpath.2025.03.009"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/cld.1265","article-title":"Prospective clinical trials and novel therapies in the medical management of severe alcohol-associated hepatitis","volume":"20","author":"Pimienta","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jgh.16087","article-title":"Mechanism of ASK1 involvement in liver diseases and related potential therapeutic targets: A critical pathway molecule worth investigating","volume":"38","author":"Chen","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Won, S.M., Park, E., Jeong, J.J., Ganesan, R., Gupta, H., Gebru, Y.A., Sharma, S., Kim, D.J., and Suk, K.T. (2021). The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158309"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Vidya Bernhardt, G., Shivappa, P., Pinto, J.R., KS, R., Ramakrishna Pillai, J., Kumar Srinivasamurthy, S., and Paul Samuel, V. (2024). Probiotics-role in alleviating the impact of alcohol liver disease and alcohol deaddiction: A systematic review. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1372755"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3350\/cmh.2020.0057","article-title":"Fecal microbiota transplantation in alcohol related liver diseases","volume":"26","author":"Shasthry","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuropharm.2017.11.019","article-title":"Minocycline protects developing brain against ethanol-induced damage","volume":"129","author":"Wang","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MEG.0000000000001311","article-title":"Long-term management of hepatic encephalopathy with lactulose and\/or rifaximin: A review of the evidence","volume":"31","author":"Hudson","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e34092","DOI":"10.1016\/j.heliyon.2024.e34092","article-title":"Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application","volume":"10","author":"Ashique","year":"2024","journal-title":"Heliyon"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.livres.2025.01.001","article-title":"New drug therapies for metabolic dysfunction-associated steatohepatitis","volume":"9","author":"Chiang","year":"2025","journal-title":"Liver Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2021.12.003","article-title":"Promises of microbiome-based therapies","volume":"76","author":"Bajaj","year":"2022","journal-title":"J. Hepatol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/10\/1196\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:58:21Z","timestamp":1759312701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/10\/1196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":87,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["antiox14101196"],"URL":"https:\/\/doi.org\/10.3390\/antiox14101196","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}